Provided by Tiger Trade Technology Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

49.09
-1.4300-2.83%
Post-market: 49.200.1100+0.22%19:59 EDT
Volume:592.57K
Turnover:29.71M
Market Cap:3.50B
PE:-15.77
High:51.11
Open:50.70
Low:49.01
Close:50.52
52wk High:94.90
52wk Low:18.26
Shares:71.31M
Float Shares:54.64M
Volume Ratio:0.80
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1128
EPS(LYR):-2.3852
ROE:-20.21%
ROA:-14.95%
PB:2.58
PE(LYR):-20.58

Loading ...

Press Release: Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 10

FACTBOX-Top pharma companies racing to launch a weight-loss pill

Reuters
·
Mar 06

A Look At Septerna (SEPN) Valuation After Recent Share Price Momentum And GPCR Pipeline Reassessment

Simply Wall St.
·
Mar 03

Stifel Nicolaus Sticks to Its Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
Feb 28

Piper Sandler Remains a Buy on Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
Feb 27

Did New Shelf Registration and Oral GLP-1 Progress Just Shift Structure Therapeutics' (GPCR) Investment Narrative?

Simply Wall St.
·
Feb 27

Analysts’ Top Healthcare Picks: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Alpha Teknova (TKNO)

TIPRANKS
·
Feb 27

Structure Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 27

Structure Therapeutics posts Q4 net income of USD 33.0 million as Q4 R&D expenses rise 105.1% to USD 68.7 million

Reuters
·
Feb 27

BRIEF-Structure Therapeutics Inc. FY Net Income USD -141.202 Million

Reuters
·
Feb 27

Structure Therapeutics Inc. FY Income From Operations USD -176.56 Million

THOMSON REUTERS
·
Feb 27

Structure Therapeutics: Cash, Cash Equivalents of $1.4 Bln as of Dec 31, 2025, Expected to Provide Cash Runway Through End of 2028

THOMSON REUTERS
·
Feb 27

Lilly, Novo Shares Fall over 2% Each. Novo Nordisk to Cut U.S. List Prices for Ozempic, Wegovy by up to 50%

Dow Jones
·
Feb 24

Septerna to Present at TD Cowen 46th Annual Health Care Conference

GlobeNewswire
·
Feb 24

Structure Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview

Reuters
·
Feb 23